Paper Review Records
All Paper Review Records
11 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
30
days
Prognostic value of preoperative circulating tumor DNA in non-small cell lung cancer: a systematic review and meta-analysis
AuthorsJiamin Lu; Yuqian Feng; Kaibo Guo; Leitao Sun; Shanming Ruan; Kai Zhang
Affiliations1. The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China; 2. The First Affiliated Hospital of Zhejiang, Chinese Medical University, (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China; 3. Hangzhou TCM Hospital of Zhejiang Chinese Medical University, Hangzhou, China; 4. Department of Oncology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China; 5. Anji Traditional Chinese Medical Hospital, Huzhou, China
141
days
The effect of resistin on the redox state of breast cancer cells
AuthorsElitsa Pavlova; Radoslav Stojchevski; Dimiter Avtanski
Affiliations1. Faculty of Physics, Sofia University “St. Kliment Ohridski”, Sofia, Bulgaria; 2. Friedman Diabetes Institute, Lenox Hill Hospital, Northwell Health, New York, USA; 3. Donald and Barbara Zucker School of Medicine at Hofstra, Northwell, Hempstead, USA; 4. Feinstein Institutes for Medical Research, Manhasset, NY, USA
55
days
Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis
AuthorsJian Wang; Miaomiao Liu; Jiaxing Sun; Zifeng Zhang
Affiliations1. Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, Xi’an, China; 2. Department of Respiratory, Tangdu Hospital, Fourth Military Medical University, Xi’an, China; 3. Department of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi’an, China
29
days
Hypofractionated versus standard chemoradiotherapy in the definitive treatment of uterine cervix cancer: interim results of a randomized controlled clinical trial
AuthorsAfsane Maddah Safaei; Ebrahim Esmati; Marzieh Gomar; Setareh Akhavan; Shahrzad Sheikh Hasani; Mona Malekzadeh Moghani; Narges Zamani; Maryam Moshtaghi; Mahrooz Malek; Fatemeh Jafari; Azadeh Sharifian; Kasra Kolahdouzan
Affiliations1. Radiation Oncology Research Center (RORC), Cancer Research Institute, Tehran University of Medical Sciences, Tehran, Iran; 2. Department of Obstetrics and Gynecology, Vali-Asr Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran; 3. Department of Oncologic Gynecology, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran; 4. Department of Radiation Oncology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 5. Radiation Oncology Department, Booali Hospital, Tehran, Iran; 6. Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Radiology Department, Imam Khomeini Hospital Complex (IKHC), Tehran University of Medical Sciences, Tehran, Iran
65
days
Predictive biomarkers for immunotherapy response in extensive-stage SCLC
AuthorsLin Zhu; Jing Qin
Affiliations1. Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China; 2. Zhejiang Key Laboratory of Diagnosis and Treatment Technology on Thoracic Oncology (Lung and Esophagus), Zhejiang Cancer Hospital, Hangzhou, People’s Republic of China
89
days
Efficacy of CDK4/6 inhibitors combined with endocrine therapy in HR+/HER2− breast cancer: an umbrella review
AuthorsDongqing Pu; Debo Xu; Yue Wu; Hanhan Chen; Guangxi Shi; Dandan Feng; Mengdi Zhang; Zhiyong Liu; Jingwei Li
Affiliations1. First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China; 2. College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China; 3. Breast Thyroid Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China; 4. Institute for Literature and Culture of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China; 5. Central Laboratory, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China
19
days
Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017
AuthorsMarkus Reitmajer; Ulrike Leiter; Lena Nanz; Teresa Amaral; Lukas Flatz; Claus Garbe; Andrea Forschner
Affiliations1. Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany
43
days
Value of high-speed videoendoscopy as an auxiliary tool in differentiation of benign and malignant unilateral vocal lesions
AuthorsJakub Malinowski; Wioletta Pietruszewska; Magdalena Kowalczyk; Ewa Niebudek-Bogusz
Affiliations1. Department of Otolaryngology, Head and Neck Oncology, Medical University of Lodz, Lodz, Poland
203
days
Analysis of laboratory parameters before the occurrence of hepatic sinusoidal obstruction syndrome in children, adolescents, and young adults after hematopoietic stem cell transplantation
AuthorsLorena Johann; Bernd Gruhn
Affiliations1. Department of Pediatrics, Jena University Hospital, Jena, Germany; 2. Comprehensive Cancer Center Central Germany (CCCG), Jena, Germany
48
days
NUDT21 interacts with NDUFS2 to activate the PI3K/AKT pathway and promotes pancreatic cancer pathogenesis
AuthorsXiao-Dong Huang; Yong-Wei Chen; Lv Tian; Li Du; Xiao-Chen Cheng; Yu-Xin Lu; Dong-Dong Lin; Feng-Jun Xiao
Affiliations1. Department of General Surgery, Xuanwu Hospital Capital Medical University, Beijing, People’s Republic of China; 2. Faculty of Hepato-Pancreato-Biliary Surgery, The First Medical Center of PLA General Hospital, Beijing, People’s Republic of China; 3. School of Nursing, Jilin University, Changchun, People’s Republic of China; 4. Department of Experimental Hematology and Biochemistry, Beijing Institute of Radiation Medicine, Beijing, People’s Republic of China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days